Healthcare Corporate Finance Deals

Acted as lead M&A Advisor to NexGen Healthcare Communications on the sale which facilitates them joining together with MedComms Experts

July 2025 | Not disclosed

Acted as lead advisor to Phoenix Equity Partners on its investment in FutureMeds

July 2025 | Not disclosed

Acted as the lead M&A advisor to Alina Homecare on the sale of its disability support division to Swanton Community Care

December 2024 | Not disclosed

Acted as lead financial advisor to Socius Pharma on the sale of the business to a Newco backed by strategic investment from CBPE and existing shareholders

October 2024 | Not disclosed

Acted as lead financial advisor to the shareholders of ABL Healt on its sale to Bay Tree PE

May 2024 | Not disclosed

Advised the shareholders of Forest Healthcare on the sale of the business to Sculptor Capital Management

February 2024 | Not disclosed

Advised the shareholders of Invivo Clinical on its sale to Microba Life Sciences

December 2023 | £11m

Acted as lead financial advisor to the shareholders of Metabolic Healthcare on the sale of the business to Pharmacy2U

October 2023 | Not disclosed

Acted as lead financial advisor to One Healthcare on the sale of its One Ashford and One Hatfield Hospitals to Phoenix Hospital Group

September 2023 | Not disclosed

Acted as lead financial advisor for Aesthetic Technology on the sale of the business to Omni Partners

January 2023 | Not disclosed

Advised Spire Healthcare Group plc on its acquisition of The Doctors Clinic Group

December 2022 | £12m

Acted as lead financial advisor to the shareholders of Herida Medical on the sale of the business to Winncare Group.

November 2022 | Not disclosed

Advised Nuffield Health on its refinancing, comprising an ESG linked bank facilities and long leasehold financing

October 2022 | £500m

Advised Sigma Pharmaceuticals plc on the refinancing of its Asset Based Facilities

October 2022 | £45m

Acted as lead advisor to Kester Capital LLP on its acquisition of iX Group (Rephine)

October 2021 | Not disclosed

Acted as lead financial advisor to Robinson Healthcare Limited on the sale of the business to HIG-backed Vernacare

March 2021 | Not disclosed

Acted as lead financial advisor to CHS Healthcare Holdings on the sale of the business to Acacium Group who are backed by the private equity house Onex
 

February 2021 | Not disclosed

Acted as financial advisor to BGF on the sale of Arcinova to Quotient

February 2021 | Not disclosed

Acted as financial advisor to The Business Growth Fund and shareholders of Renal Services UK Limited on the sale of the business to DaVita Inc.

December 2020 | Not disclosed

Acted as lead advisors to Bespoke Health & Social Care on its sale to Westbridge Fund Managers

June 2020 | Undisclosed

Acted as financial advisor to Fishawack Health on its acquisition of Skysis
 

April 2020 | Undisclosed

Acted as financial advisor to the shareholders of Fishawack Health on the sale of the business to Bridgepoint
 

April 2020 | Undisclosed

Acted as exclusive financial advisor to Medical Equipment Solutions on the sale of the business to Amethyst Radiograpy

March 2020 | Undisclosed

Acted as financial advisor to ArchiMed on the acquisition of Direct Healthcare Group
 

December 2019 | Undisclosed

Acted as independent advisor to the Trustees of Sybos on sale of NZ$338m stake in EBOS Group
 

November 2019 | Undisclosed

Acted as lead financial advisor to Elis SA on the carve-out of its decontamination services business, IHSS, to VAMED AG
 

October 2019 | Undisclosed

Acted as financial advisor to Cardinal Healthcare on its disposal to Impact REIT plc and Optima Healthcare Limited

September 2019 | £12.9 million

Acted as financial advisor to Graphite Capital on its investment in Horizon Care
 

August 2019 | Undisclosed

Acted as lead financial advisor to Elis SA on the disposal of its medical consumables division
 

July 2019 | Undisclosed

Acted as financial advisor to Fishawack on its acquisition of 2e Group LLC

 

July 2019 | Undisclosed

Acted as financial adviser to Bowmark Capital on the sale of CARE Fertility to Silverfleet Capital

May 2019 | Undisclosed

Acted as financial advisor to Clyde Vet Group on its sale to VetPartners
 

May 2019 | Undisclosed

Acted as financing advisor to support the sale by Bowmark Capital of CARE Fertility to Silverfleet Capital
 

April 2019 | £50m

Acted as financial advisor to The Good Care Group on the sale to Sodexo

 

April 2019 | Undisclosed

Acted as financial advisor to Fishawack on its acquistion of Dudnyk

March 2019 | Undisclosed

Advised Management on the sale of Sk:n to TriSpan Private Equity

February 2019 | Undisclosed

Acted as financial advisor to Fishawack on its acquistion of Blue Latitude Health
 

December 2018 | Undisclosed

Acted as financial advisor to Mangar Health on the sale of the business to Winncare Group

 

December 2018 | Undisclosed

Acted as financial advisor to Briar Dawn Veterinary Centre on the sale to CVS Group plc

October 2018 | Undisclosed

Acted as financial advisor to the shareholders of Milewood (Holdings) Limited on its sale to BC8 SPRL

September 2018 | Undisclosed

Acted as financial advisor to the shareholders of Origin Group on the sale of the business to VetPartners

July 2018 | Undisclosed

Acted as financial advisor to Wear Referrals Limited on its sale to The Linnaeus Group

July 2018 | Undisclosed